Cat. No. 5317
Chemical Name: N-[[1,1'-Biphenyl]-3-ylmethyl)-N-met
Biological Activityα/β-hydrolase domain 6 (ABHD6) inhibitor (IC50 = 0.43 μM). Blocks PTZ-induced seizures in healthy mice and spontaneous seizures in R6/2 mice. Antiepileptic activity is independent of CB1 and CB2 receptors, but is GABAA receptor dependent. Brain penetrant.
Other InformationThere appears to be some confusion about the structure of WWL 123. Tocris sells N-[[1,1'-Biphenyl]-3-ylmethyl)-N-methylcarbamic acid 4'-(aminocarbonyl)[1,1'-biphenyl]-4-yl ester [1338574-83-6], which has been confirmed by the inventor, Prof B. Cravatt, as the correct compound. Other vendors sell the corresponding 3-yl regioisomer [1338575-41-9], which is the incorrect compound.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Naydenov et al (2014) ABHD6 blockade exerts antiepileptic activity in PTZ-induced seizures and in spontaneous seizures in R6/2 mice. Neuron 83 361. PMID: 25033180 .
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses WWL 123 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: WWL 123, supplier, WWL123, epilepsy, antiepileptics, anticonvulsants, alpha, beta, hydrolase, domain, 6, ABHD6, GABAA, α, β, ahydrolase, alphahydrolase, inhibits, inhibitors, Tocris Bioscience, Other Hydrolase Inhibitor products
Find multiple products by catalog number
New Products in this Area
Non-competitive MAGL inhibitor(S)-Crizotinib
Potent MTH1 inhibitorTPPU
Potent soluble epoxide hydrolase inhibitor; orally bioavailable and brain penetrantJZP 430
Potent and irreversible α/β-hydrolase domain 6 (ABHD6) inhibitor
December 3 - 7, 2016
San Francisco, CA,